United States· US:71288-569_fed2b538-4e01-4e4b-9e92-1750554aba61
Leuprolide Acetate
A medicinal product containing leuprolide acetate, registered in United States by Meitheal Pharmaceuticals Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Leuprolide Acetate
- Manufacturer
- Meitheal Pharmaceuticals Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1171288569901 KIT in 1 CARTON (71288-569-90) * 1 VIAL, MULTI-DOSE in 1 CARTON (71288-565-03) / 2.8 mL in 1 VIAL, MULTI-DOSE * .5 mL in 1 PACKET (71288-350-91)
Regulatory notes
Same medicine, other countries
Leuprolide acetate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCAMCEVI 21 mg suspensie voor injectie met verlengde afgifteAccord Healthcare S.L.U.
- FinlandCAMCEVIAccord Healthcare S.L.U.
- United KingdomCamcevi 42mg prolonged-release suspension for injection pre-filled syringesAccord-UK Ltd
- SwedenCAMCEVI 21 mg Injektionsvätska, depotsuspensionAccord Healthcare S.L.U.
- GermanyEligardPb Pharma Gmbh
- IrelandCAMCEVI 21 mg prolonged-release suspension for injectionAccord Healthcare S.L.U.
- CzechiaCAMCEVIAccord Healthcare S.L.U., Barcelona
- SpainCAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADAAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Eligard Depot, Enantone Monats-Depot
- Belgium · Depo-Eligard
- Bulgaria · Елигард, Лутрат Депо
- Cyprus · Eligard
- Czechia · Eligard, Leptoprol
- Germany · Eligard, Enantone Monats-Depot
- Denmark · Eligard, Leuprorelin Sandoz
- Estonia · Eligard
- Spain · Eligard Semestral, Eligard Trimestral
- Finland · Eligard, Enanton Depot Dual
- France · Eligard, Enantone Lp
- United Kingdom (Northern Ireland) · Prostap 3 Dcs, Prostap Pd Dcs
- Greece · Deplanda, Elityran
- Croatia · Eligard, Lerin
- Hungary · Eligard, Leuprorelin Pharmacenter
- Ireland · Eligard, Leuprex 3
- Iceland · Camcevi, Eligard
- Italy · Eligard, Enantone
- Liechtenstein · Camcevi
- Lithuania · Eligard
- Luxembourg · Depo-Eligard, Leugon
- Latvia · Eligard, Leptoprol
- Malta · Deplanda
- Netherlands · Eligard, Leuproreline Sandoz
- Norway · Camcevi, Eligard
- Poland · Eligard, Leuprostin
- Portugal · Eligard, Lutrate Depot
- Romania · Eligard, Leptoprol
- Sweden · Eligard, Enanton Depot Dual
- Slovenia · Eligard, Leptoprol
- Slovakia · Eligard, Leuprorelin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9277d32-c394-4d31-8af2-fa41352025b4 GET /v1/drugs/f9277d32-c394-4d31-8af2-fa41352025b4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"35634415-000f-47db-9bd7-9e16eef3f02e": {
"match": "brand_token",
"title": "LEUPROLIDE ACETATE (LEUPROLIDE ACETATE) KIT [ZYDUS PHARMACEUTICALS USA INC.]",
"spl_version": "6",
"published_date": "2026-05-28"
}
},
"productid": "71288-569_fed2b538-4e01-4e4b-9e92-1750554aba61",
"productndc": "71288-569",
"dosage_form": "KIT",
"orange_book": {
"appl_no": "075471",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "14MG/2.8ML (1MG/0.2ML)",
"product_no": "001",
"approval_date": "Oct 25, 2000"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": null,
"proprietary_name": "Leuprolide Acetate",
"active_ingred_unit": null,
"application_number": "ANDA075471",
"marketing_category": "ANDA",
"nonproprietary_name": "Leuprolide Acetate",
"start_marketing_date": "20240515",
"active_numerator_strength": null
}See everything about leuprolide acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.